Simon Goldenberg
About
Simon Goldenberg is a scholar working on Infectious Diseases, Epidemiology and Surgery.
According to data from OpenAlex, Simon Goldenberg has authored 90 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Infectious Diseases, 45 papers in Epidemiology and 13 papers in Surgery. Recurrent topics in Simon Goldenberg's work include Clostridium difficile and Clostridium perfringens research (47 papers), Microscopic Colitis (28 papers) and Viral gastroenteritis research and epidemiology (14 papers). Simon Goldenberg is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (47 papers), Microscopic Colitis (28 papers) and Viral gastroenteritis research and epidemiology (14 papers). Simon Goldenberg collaborates with scholars based in United Kingdom, United States and Netherlands. Simon Goldenberg's co-authors include Jonathan A. Otter, Saber Yezli, Sam Douthwaite, Curtis J. Donskey, David J. Weber, G.L. French, Jonathan D. Edgeworth, Karen Bisnauthsing, Blair Merrick and Amita Patel and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and Gut.
In The Last Decade
Simon Goldenberg
89 papers receiving 2.8k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Simon Goldenberg United Kingdom | 25 | 1.7k | 972 | 612 | 307 | 301 | 90 | 2.9k | ||
| Colleen S. Kraft United States | 36 | 3.3k 1.9× | 1.7k 1.7× | 1.0k 1.7× | 408 1.3× | 487 1.6× | 177 | 5.2k | ||
| Mini Kamboj United States | 30 | 2.1k 1.2× | 1.2k 1.3× | 649 1.1× | 384 1.3× | 204 0.7× | 127 | 3.4k | ||
| Maria J. G. T. Vehreschild Germany | 35 | 3.7k 2.1× | 2.0k 2.0× | 797 1.3× | 484 1.6× | 305 1.0× | 161 | 5.4k | ||
| Andi L. Shane United States | 27 | 1.3k 0.8× | 1.4k 1.5× | 509 0.8× | 207 0.7× | 460 1.5× | 88 | 4.2k | ||
| Louis Valiquette Canada | 31 | 2.4k 1.3× | 2.1k 2.2× | 268 0.4× | 656 2.1× | 282 0.9× | 110 | 3.9k | ||
| Young Goo Song South Korea | 31 | 921 0.5× | 1.3k 1.3× | 281 0.5× | 577 1.9× | 253 0.8× | 220 | 3.3k | ||
| Eugene Athan Australia | 33 | 1.6k 0.9× | 2.0k 2.0× | 380 0.6× | 599 2.0× | 137 0.5× | 141 | 3.4k | ||
| Susan Whittier United States | 41 | 1.9k 1.1× | 1.5k 1.6× | 820 1.3× | 391 1.3× | 465 1.5× | 118 | 4.7k | ||
| Denise Gravel Canada | 26 | 1.5k 0.8× | 864 0.9× | 323 0.5× | 229 0.7× | 397 1.3× | 60 | 2.5k | ||
| Luís Alcalá Spain | 37 | 2.5k 1.5× | 2.2k 2.3× | 336 0.5× | 637 2.1× | 137 0.5× | 160 | 3.9k |
Countries citing papers authored by Simon Goldenberg
Since
Specialization
Citations
This map shows the geographic impact of Simon Goldenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Goldenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Goldenberg more than expected).
Fields of papers citing papers by Simon Goldenberg
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Simon Goldenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Goldenberg. The network helps show where Simon Goldenberg may publish in the future.
Co-authorship network of co-authors of Simon Goldenberg
This figure shows the co-authorship network connecting the top 25 collaborators of Simon Goldenberg. A scholar is included among the top collaborators of Simon Goldenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Goldenberg. Simon Goldenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Zain, Nur Masirah M., Blair Merrick, Lindsey Edwards, et al.. (2025). Bacterial diversity, viability and stability in lyophilised faecal microbiota capsules support ongoing clinical use. International Journal of Pharmaceutics. 678. 125703–125703.
2.
Merrick, Blair, Elizabeth Allen, Karen Bisnauthsing, et al.. (2025). Faecal microbiota transplant to ERadicate gastrointestinal carriage of Antibiotic-Resistant Organisms (FERARO): A feasibility randomised controlled trial. Journal of Infection. 91(1). 106504–106504.
3.
Mullish, Benjamin H., Blair Merrick, Mohammed Nabil Quraishi, et al.. (2024). The use of faecal microbiota transplant as treatment for recurrent or refractoryClostridioides difficileinfection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines. Gut. 73(7). 1–24.
4.
Snell, Luke B., Adela Alcolea-Medina, Themoula Charalampous, et al.. (2024). The drainome: longitudinal metagenomic characterization of wastewater from hospital ward sinks to characterize the microbiome and resistome and to assess the effects of decontamination interventions. Journal of Hospital Infection. 153. 55–62.
5.
Alcolea-Medina, Adela, Christopher Alder, Luke B. Snell, et al.. (2024). Unified metagenomic method for rapid detection of microorganisms in clinical samples. SHILAP Revista de lepidopterología. 4(1). 135–135.
6.
Merrick, Blair, Chrysi Sergaki, Lindsey Edwards, et al.. (2023). Modulation of the Gut Microbiota to Control Antimicrobial Resistance (AMR)—A Narrative Review with a Focus on Faecal Microbiota Transplantation (FMT). Infectious Disease Reports. 15(3). 238–254.
7.
Gordon, Jason, et al.. (2023). Estimating the Treatment and Prophylactic Economic Value of New Antimicrobials in Managing Antibiotic Resistance and Serious Infections for Common Pathogens in the USA: A Population Modelling Study. PharmacoEconomics. 42(3). 329–341.
8.
Goldenberg, Simon, Andrew Dodgson, Gavin Barlow, et al.. (2022). Epidemiology, Outcomes and Resource Utilisation in Patients with Carbapenem Non-susceptible Gram-Negative Bacteria in the UK: A Retrospective, Observational Study (CARBAR UK). Advances in Therapy. 39(8). 3602–3615.
9.
Merrick, Blair, et al.. (2020). Regulation, risk and safety of Faecal Microbiota Transplant. Infection Prevention in Practice. 2(3). 100069–100069.
10.
Österdahl, Marc F., Karla A. Lee, Mary Ní Lochlainn, et al.. (2020). Detecting SARS-CoV-2 at point of care: preliminary data comparing loop-mediated isothermal amplification (LAMP) to polymerase chain reaction (PCR). BMC Infectious Diseases. 20(1). 783–783.
11.
Otter, Jonathan A., et al.. (2019). Individual- and community-level risk factors for ESBL Enterobacteriaceae colonization identified by universal admission screening in London. Clinical Microbiology and Infection. 25(10). 1259–1265.
12.
Patel, Vishal, Simon Goldenberg, Alberto Sánchez‐Fueyo, et al.. (2019). PROFIT, a PROspective, randomised placebo controlled feasibility trial of Faecal mIcrobiota Transplantation in cirrhosis: study protocol for a single-blinded trial. BMJ Open. 9(2). e023518–e023518.
13.
Guéry, Benoît, Francesco Menichetti, Veli-Jukka Anttila, et al.. (2017). Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial. The Lancet Infectious Diseases. 18(3). 296–307.
14.
Goldenberg, Simon, et al.. (2017). Existing and investigational therapies for the treatment of Clostridium difficile infection: A focus on narrow spectrum, microbiota-sparing agents. Médecine et Maladies Infectieuses. 48(1). 1–9.
15.
Batra, Rahul, et al.. (2016). Molecular detection of common intestinal parasites: a performance evaluation of the BD Max™ Enteric Parasite Panel. European Journal of Clinical Microbiology & Infectious Diseases. 35(11). 1753–1757.
16.
Kleef, Esther van, Sarah R Deeny, Mark Jit, et al.. (2016). The projected effectiveness of Clostridium difficile vaccination as part of an integrated infection control strategy. Vaccine. 34(46). 5562–5570.
17.
Biswas, Jason, Amita Patel, Jonathan A. Otter, et al.. (2015). Reduction in Clostridium difficile environmental contamination by hospitalized patients treated with fidaxomicin. Journal of Hospital Infection. 90(3). 267–270.
18.
Goldenberg, Simon, Karen Bisnauthsing, Amita Patel, et al.. (2014). Point-of-Care Testing for Clostridium Difficile Infection: A Real-World Feasibility Study of a Rapid Molecular Test in Two Hospital Settings. Infectious Diseases and Therapy. 3(2). 295–306.
19.
Goldenberg, Simon, et al.. (2012). Performance of the GeneXpert CT/NG Assay Compared to That of the Aptima AC2 Assay for Detection of Rectal Chlamydia trachomatis and Neisseria gonorrhoeae by Use of Residual Aptima Samples. Journal of Clinical Microbiology. 50(12). 3867–3869.
20.
Goldenberg, Simon, et al.. (2010). Detection of toxigenic Clostridium difficile in diarrheal stools by rapid real-time polymerase chain reaction. Diagnostic Microbiology and Infectious Disease. 67(3). 304–307.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Colleen S. Kraft Breakdown of academic impact, for papers by Mini Kamboj Breakdown of academic impact, for papers by Maria J. G. T. Vehreschild Breakdown of academic impact, for papers by Andi L. Shane Breakdown of academic impact, for papers by Louis Valiquette Breakdown of academic impact, for papers by Young Goo Song Breakdown of academic impact, for papers by Eugene Athan Breakdown of academic impact, for papers by Susan Whittier Breakdown of academic impact, for papers by Denise Gravel Breakdown of academic impact, for papers by Luís Alcalá